Ann: Colombian Medicinal Cannabis Acquisition, page-97

Only cash flow problems I can see are from weak so called investors selling out at a loss. Oh well it’s only money. CPH are primed for far better returns than $1.60 per share in next 6-12 months IMO. They have just completed a substantial raise at $1.10 per share, so no credit raising needed for now. If and when another CR is needed, I’m sure it will be for the better of the company growth and long term objectives.